This site is optimised for modern browsers. For the best experience, please use Google Chrome, Mozilla Firefox, or Microsoft Edge.

Call for Patients in Gateshead to Join Biggest Ever Study into Triggers for Inflammatory Bowel Disease

Call for Patients in Gateshead to Join Biggest Ever Study into Triggers for Inflammatory Bowel Disease

When 29-year-old games designer and keen motorcyclist, Emily Knox, was diagnosed with ulcerative colitis, she found her lifestyle suddenly changed dramatically. But thanks to treatment, her condition is now under control.

Now, she is taking part in research at Gateshead Health NHS Foundation Trust that aims to discover the causes of inflammatory bowel disease (IBD) and help lead to a cure.

Researchers in Gateshead are looking for people with Crohn’s disease and ulcerative colitis to take part in a major study into the triggers of flares in inflammatory bowel disease.

Inflammatory bowel disease (IBD) affects about 1 in 20 people in the UK – particularly young people.

It can make sufferers quite weak, typically giving them abdominal pain, diarrhoea, nausea and lethargy. The symptoms can be extreme enough to affect all aspects of day-to-day living.

Now, PREdiCCT, the biggest study of its kind, is using the latest digital technology to better understand the factors that trigger or increase the risk of a flare – from diet to sleep, stress levels and work patterns.

Dr Dina Mansour, consultant gastroenterologist, Gateshead Health NHS Foundation Trust, said: “In recent years, we’ve got better at understanding the genetic risk factors and some of the disturbances in the immune system that lead to IBD.

“However, we are still a long way from knowing just what triggers a flare and or predicting what course the illness will follow in any given individual.

“The aim of the PREdiCCt study is to help us understand how factors in the environment, including diet and the bugs that live in the gut, increase or reduce the risk of a flare in Crohn’s and colitis.

“It will yield a lot of new information to help sufferers right away; but the information will also help to kick start many important future studies that will bring us ever closer to a cure for Crohn’s disease and ulcerative colitis.”

The study is coordinated by the University of Edinburgh and NHS Lothian and has contributions from gastroenterologists across the UK. It is looking to recruit 3,100 people with Crohn’s or colitis which is currently well controlled.

Participation involves one face-to-face consultation before researchers use digital technologies to follow the disease course of individuals over two years whilst collecting information on the food they eat, their lifestyle, stress levels, gut bacteria, as well as DNA.

It is hoped that it may then be possible to find a link between these factors and the severity of each participant’s symptom flares.

Emily Knox, 29, a games designer, from Haydon Bridge, Northumberland, was diagnosed with ulcerative colitis a year ago and has recently joined the study

She said: “When I was first diagnosed, I knew very little about Crohn’s and colitis. At its worst, I was having up to 15 bowel movements a day, which meant I was worried about ever going too far away from a toilet and I would get very bloated.

“It meant that I was no longer confident in taking part in some activities I enjoyed, such as road trips on my motorbike.

“But now, thanks to medication, the symptoms are now well controlled.

“I think people can still be squeamish about talking about problems involving bowels and I probably was too when I was first diagnosed. But they can have a big impact on people’s quality of life and I’m happy to talk about my condition now as I think it’s important to raise awareness.

“IBD affects different people in different ways and so I was really keen to get involved in research that may help to find out more about the causes and hopefully one day lead to a cure. It is a good feeling to think that by taking part in this study, I may be able to help other people with the condition in the future.”

This study is open to anyone over the age of six years who has a confirmed diagnosis of Crohn’s disease or ulcerative colitis which is currently well controlled. ​

To find out more please contact the Queen Elizabeth Hospital research nurses on 0191 445 8414/0191 445 6283 or visit: QE Gateshead Research

To discover other NIHR studies please visit: https://bepartofresearch.nihr.ac.uk